Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02225678 · ClinicalTrials.gov registry record
Minimally Invasive Biomarker for Asthma Disease Severity
A clinical trial of Healthy and Asthma, sponsored by Mayo Clinic.
- Completed
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT02225678: Completed study of Healthy and Asthma, sponsored by Mayo Clinic.
NCT02225678 is a study of Healthy and Asthma that has completed, run by Mayo Clinic. The registered enrollment target is 25 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02225678, a study of Healthy and Asthma, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
Can a clinical test be developed that could help manage asthma symptoms?
Study Locations (1)
Arizona
- Mayo Clinic in Arizona - Scottsdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02225678
The ClinicalTrials.gov registry entry for NCT02225678 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Healthy appearing as the primary indexed condition, and to 0 interventions.
NCT02225678 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT02225678 about?
NCT02225678 is a clinical study titled "Minimally Invasive Biomarker for Asthma Disease Severity". Can a clinical test be developed that could help manage asthma symptoms?
What is the current status of trial NCT02225678?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2014-07. Estimated completion is 2015-06.
What conditions does trial NCT02225678 study?
This clinical trial studies the following conditions: Healthy, Asthma.
Who is sponsoring clinical trial NCT02225678?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02225678 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mapping Auricular Vagus Nerve Circuitry
RECRUITING · Early Phase 1
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
RECRUITING
-
Breathing & Blood Pressure
RECRUITING
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.